Publicaciones en colaboración con investigadores/as de Goethe University Frankfurt (4)

2009

  1. Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration

    PLoS ONE, Vol. 4, Núm. 6

2006

  1. An overview of Parkinson's disease and the cannabinoid system and possible benefits of cannabinoid-based treatments

    Current Medicinal Chemistry, Vol. 13, Núm. 30, pp. 3705-3718

2005

  1. Cannabinoid CB1 receptors in the basal ganglia and motor response to activation or blockade of these receptors in parkin-null mice

    Brain Research, Vol. 1046, Núm. 1-2, pp. 195-206

  2. Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: Relevance to Parkinson's disease

    Neurobiology of Disease, Vol. 19, Núm. 1-2, pp. 96-107